Clastellos

Clastellos (Raloxifene Hydrochloride) is a medication used to prevent and treat osteoporosis in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).

Clastellos is primarily used to prevent and treat osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in some tissues, such as bone, while blocking estrogen's effects in others, like the uterus and breasts. This dual action helps to maintain bone density and reduce the risk of fractures. Clastellos is also sometimes used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease.

Common effects of Clastellos may include hot flashes, leg cramps, and swelling in the legs or feet. Some users may also experience flu-like symptoms, joint pain, or headache. These effects are usually mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Clastellos should be used with caution in individuals with a history of blood clots, liver disease, or high levels of triglycerides. It is important to inform your healthcare provider about any medical conditions or allergies before starting Clastellos. Regular monitoring may be required to ensure the medication is working effectively and safely.

Clastellos may interact with certain medications, including cholesterol-lowering drugs, blood thinners, and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Clastellos, as it may increase the risk of side effects.